Quercetin
Drug profile
Also known as: quercetine, quercetol, quertine, xanthaurine
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Quercetin is a drug catalogued in DrugCentral. DrugCentral lists 163 molecular targets, including MAOA, CYP19A1 and AKR1B1.
- Molecular targets: MAOA, CYP19A1, AKR1B1 and fabI (163 listed in DrugCentral).
- Molecular formula: C15H10O7; molecular weight 302.24 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Contraindications (5)
- Anemia due to enzyme deficiency
- Hb SS disease
- Hemochromatosis
- Kidney disease
- Primary hyperoxaluria
Mechanism & targets
Molecular targets (163)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Amine oxidase [flavin-containing] A | MAOA | unknown | IC50 8.00 |
| Aromatase | CYP19A1 | unknown | IC50 7.92 |
| Aldose reductase | AKR1B1 | unknown | IC50 7.83 |
| Enoyl-acyl-carrier protein reductase | fabI | unknown | Ki 7.66 |
| Serine/threonine-protein kinase pim-1 | PIM1 | unknown | Kd 7.60 |
| Prothrombin | F2 | unknown | Kd 7.41 |
| 5'-nucleotidase | Nt5e | unknown | Ki 7.34 |
| Cytochrome P450 1B1 | CYP1B1 | unknown | IC50 7.11 |
| Proto-oncogene tyrosine-protein kinase Src | SRC | unknown | IC50 6.92 |
| Arachidonate 5-lipoxygenase | Alox5 | unknown | IC50 6.70 |
| Vascular endothelial growth factor receptor 2 | KDR | unknown | IC50 6.55 |
| Insulin-like growth factor 1 receptor | IGF1R | unknown | IC50 6.52 |
| Arachidonate 15-lipoxygenase | ALOX15 | unknown | IC50 6.37 |
| Arachidonate 12-lipoxygenase, 12S-type | ALOX12 | unknown | IC50 6.36 |
| Cyclin-dependent kinase 1 | CDK1 | unknown | IC50 6.35 |
| Tyrosine-protein kinase Yes | YES1 | unknown | Ki 6.33 |
| Hepatocyte growth factor receptor | MET | unknown | IC50 6.24 |
| Receptor-type tyrosine-protein kinase FLT3 | FLT3 | unknown | IC50 6.23 |
| Integrase | pol | unknown | IC50 6.22 |
| NADPH oxidase 4 | NOX4 | unknown | IC50 6.17 |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Drug ineffective for unapproved indication | 60.7 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Quercetin is on its molecule page.
| Molecular formula | C15H10O7 |
|---|---|
| Molecular weight | 302.24 g/mol |
| CAS number | 117-39-5 |
| InChIKey | REFJWTPEDVJJIY-UHFFFAOYSA-N |
| PubChem CID | 5280343 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Quercetin work?
Its molecular targets in DrugCentral include MAOA, CYP19A1, AKR1B1 and fabI.
What is the chemical formula of Quercetin?
Quercetin has the molecular formula C15H10O7 and a molecular weight of 302.24 g/mol.
Browse: all drugs starting with Q · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 3514 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL50 — compound record and bioactivity
- PubChem CID 5280343 — chemical identifiers
- DrugBank DB04216 — drug record
- FDA UNII 9IKM0I5T1E — substance identity
- UniProt P11511 (CYP19A1) — target protein
- UniProt P15121 (AKR1B1) — target protein
- UniProt P11309 (PIM1) — target protein
- UniProt P00734 (F2) — target protein
- UniProt Q16678 (CYP1B1) — target protein
- UniProt P12931 (SRC) — target protein
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.